Literature DB >> 11889064

The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers.

L A Houghton1, R Lea, N Jackson, P J Whorwell.   

Abstract

BACKGROUND: We have previously shown that the menstrual cycle has no effect on rectal sensitivity of normal healthy women, despite them having looser stools at the time of menses. Patients with irritable bowel syndrome (IBS) often report significant exacerbation of their IBS symptoms with menses, raising the possibility that IBS patients may respond differently to the menstrual cycle. AIM AND METHODS: Rectal responses to balloon distension during days 1-4 (menses), 8-10 (follicular phase), 18-20 (luteal phase), and 24-28 (premenstrual phase) of the menstrual cycle were assessed in 29 female IBS patients (aged 21-44 years), diagnosed by the Rome I criteria. During the course of the study patients completed symptom diaries to assess abdominal pain and bloating (visual analogue scale), and frequency and consistency of bowel habits. In addition, levels of anxiety and depression were assessed using the hospital anxiety and depression questionnaire.
RESULTS: Menses was associated with a worsening of abdominal pain and bloating compared with most other phases of the menstrual cycle (p<0.05). Bowel habits also became more frequent (p<0.05) and patients tended to have a lower general well being. Rectal sensitivity increased at menses compared with all other phases of the cycle (p<0.05). There was no associated change in rectal compliance, wall tension, or motility index. Neither was there any difference in resting anal pressure or the distension volumes required to relax the internal anal sphincter during the menstrual cycle.
CONCLUSION: These data (1) confirm that IBS symptomatology is exacerbated at menses and (2) show for the first time that in contrast with healthy women, rectal sensitivity changes with the menstrual cycle. These cyclical changes in sensitivity suggest that women with IBS respond differently to fluctuations in their sex hormonal environment or its consequences compared with healthy females.

Entities:  

Mesh:

Year:  2002        PMID: 11889064      PMCID: PMC1773170          DOI: 10.1136/gut.50.4.471

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  The irritable bowel syndrome.

Authors:  D A Drossman; D W Powell; J T Sessions
Journal:  Gastroenterology       Date:  1977-10       Impact factor: 22.682

2.  Altered bowel habit and menstruation.

Authors:  W D Rees; J Rhodes
Journal:  Lancet       Date:  1976-08-28       Impact factor: 79.321

3.  Gastrointestinal transit: the effect of the menstrual cycle.

Authors:  A Wald; D H Van Thiel; L Hoechstetter; J S Gavaler; K M Egler; R Verm; L Scott; R Lester
Journal:  Gastroenterology       Date:  1981-06       Impact factor: 22.682

4.  Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with the irritable bowel syndrome.

Authors:  J Rogers; M M Henry; J J Misiewicz
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

5.  Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome.

Authors:  P Welgan; H Meshkinpour; M Beeler
Journal:  Gastroenterology       Date:  1988-05       Impact factor: 22.682

6.  Bowel function measurements of individuals with different eating patterns.

Authors:  G J Davies; M Crowder; B Reid; J W Dickerson
Journal:  Gut       Date:  1986-02       Impact factor: 23.059

7.  Do male sex hormones protect from irritable bowel syndrome?

Authors:  L A Houghton; N A Jackson; P J Whorwell; J Morris
Journal:  Am J Gastroenterol       Date:  2000-09       Impact factor: 10.864

8.  Evidence for exacerbation of irritable bowel syndrome during menses.

Authors:  W E Whitehead; L J Cheskin; B R Heller; J C Robinson; M D Crowell; C Benjamin; M M Schuster
Journal:  Gastroenterology       Date:  1990-06       Impact factor: 22.682

9.  The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study.

Authors:  S V Kane; K Sable; S B Hanauer
Journal:  Am J Gastroenterol       Date:  1998-10       Impact factor: 10.864

10.  Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide.

Authors:  F Narducci; G Bassotti; M T Granata; M A Pelli; M Gaburri; R Palumbo; A Morelli
Journal:  Dig Dis Sci       Date:  1986-03       Impact factor: 3.199

View more
  60 in total

1.  Differences between male and female responses to painful thermal and mechanical stimulation of the human esophagus.

Authors:  Jan Pedersen; Hariprasad Reddy; Peter Funch-Jensen; Lars Arendt-Nielsen; Hans Gregersen; Asbjørn Mohr Drewes
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

2.  Prevalence and risk factors for abdominal bloating and visible distention: a population-based study.

Authors:  X Jiang; G R Locke; R S Choung; A R Zinsmeister; C D Schleck; N J Talley
Journal:  Gut       Date:  2008-06       Impact factor: 23.059

3.  A clinically relevant animal model of temporomandibular disorder and irritable bowel syndrome comorbidity.

Authors:  Richard J Traub; Dong-Yuan Cao; Jane Karpowicz; Sangeeta Pandya; Yaping Ji; Susan G Dorsey; Dean Dessem
Journal:  J Pain       Date:  2014-06-26       Impact factor: 5.820

Review 4.  Bloating and Abdominal Distension: Old Misconceptions and Current Knowledge.

Authors:  Juan R Malagelada; Anna Accarino; Fernando Azpiroz
Journal:  Am J Gastroenterol       Date:  2017-05-16       Impact factor: 10.864

5.  Irritable bowel syndrome is more common in women regardless of the menstrual phase: a Rome II-based survey.

Authors:  Sun-Young Lee; Jeong Hwan Kim; In-Kyung Sung; Hyung Seok Park; Choon-Jo Jin; Won Hyeok Choe; So Young Kwon; Chang Hong Lee; Kyoo Wan Choi
Journal:  J Korean Med Sci       Date:  2007-10       Impact factor: 2.153

6.  Visceral sensitivity in irritable bowel syndrome and healthy volunteers: reproducibility of the rectal barostat.

Authors:  Signe Spetalen; Morten B Jacobsen; Morten H Vatn; Svein Blomhoff; Leiv Sandvik
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

7.  Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome.

Authors:  Tisha N Lunsford; Lucinda A Harris
Journal:  Int J Womens Health       Date:  2010-10-27

8.  Expression of G protein-coupled estrogen receptor in irritable bowel syndrome and its clinical significance.

Authors:  Bin Qin; Lei Dong; Xiaoyan Guo; Jiong Jiang; Yangxin He; Xiaoyan Wang; Lu Li; Juhui Zhao
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

9.  Analysis of rectal dynamic and static compliances in patients with irritable bowel syndrome.

Authors:  Jung Ho Park; Yoo Hum Baek; Dong I L Park; Hong Joo Kim; Yong Kyun Cho; Chong I L Sohn; Woo Kyu Jeon; Byung Ik Kim; Poong-Lyul Rhee
Journal:  Int J Colorectal Dis       Date:  2008-03-21       Impact factor: 2.571

10.  Rectal visceral sensitivity in women with irritable bowel syndrome without psychiatric comorbidity compared with healthy volunteers.

Authors:  Signe Spetalen; Leiv Sandvik; Svein Blomhoff; Morten B Jacobsen
Journal:  Gastroenterol Res Pract       Date:  2009-09-17       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.